Favorable pre-clinical data support efficacy of vaccine for gonorrhea

Intravacc Announces Favorable Preclinical Data for its Candidate Intranasal Gonorrhea Vaccine Avacc® 11

Read the publication

Download the Press Release

Download the Avacc® 11 Vaccsheet

Contact us

You can send us an email:
info@intravacc.nl

Reach out to Business Development: 
BD@intravacc.nl

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!

 

Contact form

Subscribe to our newsletter